Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2015 · 10-Q
Revenue$275.47K$275.47K+110.6% vs Q1 2014 Net Income-$203.17K-$203.17KN/M vs Q1 2014 EPS Diluted$0.00$0.00N/M vs Q1 2014 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Margins · derivedOperating margin-2.8%
Net margin-73.8%+748.8 pt vs Q1 2014
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end